Crossmark

A case of unresectable locally advanced intrahepatic cholangiocarcinoma that achieved pathological complete response after gemcitabine and S1 chemotherapy

Crossref DOI link: https://doi.org/10.1007/s12328-022-01700-x

Published Online: 2022-10-01

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sumiyoshi, Tatsuaki

Uemura, Kenichiro https://orcid.org/0000-0003-0003-6268
Shintakuya, Ryuta

Okada, Kenjiro

Otsuka, Hiroyuki

Serikawa, Masahiro

Ishii, Yasutaka

Tsuboi, Tomofumi

Arihiro, Koji

Takahashi, Shinya
License Information

Text and Data Mining valid from 2022-10-01

Version of Record valid from 2022-10-01
More Information

Article History

Received: 15 July 2022

Accepted: 4 September 2022

First Online: 1 October 2022

Declarations

:

: The authors declare that they have no conflicts of interest.

: All procedures performed in this study involving human participants were in accordance with the institutional ethics committee and with the 1964 Helsinki Declaration and its later amendments.

: Informed consent was obtained from the patient included in this study.

Document is current

Any future updates will be listed below